STEPHEN E. STRAUS, M.D.; HOLLY A. SMITH, B.S.; CHAIM BRICKMAN, M.D.; PAULO de MIRANDA, Ph.D.; COLIN McLAREN, Ph.D.; RONALD E. KEENEY, M.D.
Over 25 episodes of severe chronic and recurrent mucocutaneous herpes simplex virus infections in five immunodeficient patients were successfully treated with intravenous or oral acyclovir treatment. Acyclovir was shown to inhibit viral shedding rapidly, to be well tolerated, and to permit the complete healing of lesions. As expected, a course of acyclovir did not prevent later recurrences of the herpes virus infections. However, symptomatic recurrences were successfully suppressed during long (up to 65-day) courses of oral acyclovir.
Learn more about subscription options.
Register Now for a free account.
STRAUS SE, SMITH HA, BRICKMAN C, de MIRANDA P, McLAREN C, KEENEY RE. Acyclovir for Chronic Mucocutaneous Herpes Simplex Virus Infection in Immunosuppressed Patients. Ann Intern Med. 1982;96:270–277. doi: 10.7326/0003-4819-96-3-270
Download citation file:
Published: Ann Intern Med. 1982;96(3):270-277.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only